
Texas Capital Bancshares: The 7% Preferred Stock Is Attractive
Seeking Alpha
Published: Aug 23, 2026, 02:40 PM
The Investment Doctor Investing Group Leader Follow Summary Texas Capital Bancshares demonstrates robust earnings growth, with H1 2026 EPS up double digits and strong balance sheet expansion. TCBI covers preferred dividends with just 5% of net profit, yielding a coverage ratio near 2000%, providing significant security for preferred shareholders. The Series B preferred (TCBIO) offers a 6.96% yield at $20.66, is non-cumulative, and callable at $25, presenting a compelling risk/reward profile. TCBI's tangible book value is just under $77 per share; consensus sees EPS exceeding $8 in 2027, supporting both common and preferred investment theses. Looking for more investing ideas like this one? Get them exclusively at European Small-Cap Ideas. Learn More » chapin31/iStock via Getty Images Introduction Texas Capital Bancshares ( TCBI ) is the holding company of the Texas Capital Bank. As the bank does not pay a dividend on its common shares , it is able to grow the balance This article was written by The Investment Doctor 23.98K Followers Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly believes a portfolio should consist of a mixture of dividend and growth stocks. He is the leader of the investment group European Small Cap Ideas which offers exclusive access to actionable research on appealing Europe-focused investment opportunities not found elsewhere. The a focus is on high-quality ideas in the small-cap space, with emphasis on capital gains and dividend income for continuous cash flow. Features include: two model portfolios - the European Small Cap Ideas portfolio and the European REIT Portfolio, weekly updates, educational content to learn more about the European investing opportunities, and an active chat room to discuss the latest developments of the portfolio holdings. Learn more. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. I may initiate a long position in TCBI and/or TCBIO but this is unlikely to happen within the next 72 hours. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Source: Seeking Alpha
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.